Progression and complications after external beam radiation therapy for carcinoma of prostate

Maurizio Brausi, Mark S. Soloway

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Sixty patients with prostatic carcinoma localized to the pelvis have been treated by external beam radiation therapy: 2 patients (2 %) were Stage A, 12 (20 %) Stage B, 14 (23 %) Stage C, and 32 (53 %) Stage Dl. Twenty-two patients received adjuvant therapy (11 estramustine phosphate [Estracyt] and 11 cyclophosphamide [Cytoxan]) after radiation. Progression occurred in 22 patients (37 %): 6 (10 %) had local recurrence while 16 (27 %) failed distally. The incidence of late major complications was 12 percent.

Original languageEnglish
Pages (from-to)115-119
Number of pages5
JournalUrology
Volume34
Issue number3
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Prostate
Radiotherapy
Estramustine
Carcinoma
Cyclophosphamide
Pelvis
Phosphates
Radiation
Recurrence
Incidence
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Progression and complications after external beam radiation therapy for carcinoma of prostate. / Brausi, Maurizio; Soloway, Mark S.

In: Urology, Vol. 34, No. 3, 01.01.1989, p. 115-119.

Research output: Contribution to journalArticle

Brausi, Maurizio ; Soloway, Mark S. / Progression and complications after external beam radiation therapy for carcinoma of prostate. In: Urology. 1989 ; Vol. 34, No. 3. pp. 115-119.
@article{50e54ea3282e4cb1ad21c8ba130bc7f6,
title = "Progression and complications after external beam radiation therapy for carcinoma of prostate",
abstract = "Sixty patients with prostatic carcinoma localized to the pelvis have been treated by external beam radiation therapy: 2 patients (2 {\%}) were Stage A, 12 (20 {\%}) Stage B, 14 (23 {\%}) Stage C, and 32 (53 {\%}) Stage Dl. Twenty-two patients received adjuvant therapy (11 estramustine phosphate [Estracyt] and 11 cyclophosphamide [Cytoxan]) after radiation. Progression occurred in 22 patients (37 {\%}): 6 (10 {\%}) had local recurrence while 16 (27 {\%}) failed distally. The incidence of late major complications was 12 percent.",
author = "Maurizio Brausi and Soloway, {Mark S.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0090-4295(89)90242-2",
language = "English",
volume = "34",
pages = "115--119",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Progression and complications after external beam radiation therapy for carcinoma of prostate

AU - Brausi, Maurizio

AU - Soloway, Mark S.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Sixty patients with prostatic carcinoma localized to the pelvis have been treated by external beam radiation therapy: 2 patients (2 %) were Stage A, 12 (20 %) Stage B, 14 (23 %) Stage C, and 32 (53 %) Stage Dl. Twenty-two patients received adjuvant therapy (11 estramustine phosphate [Estracyt] and 11 cyclophosphamide [Cytoxan]) after radiation. Progression occurred in 22 patients (37 %): 6 (10 %) had local recurrence while 16 (27 %) failed distally. The incidence of late major complications was 12 percent.

AB - Sixty patients with prostatic carcinoma localized to the pelvis have been treated by external beam radiation therapy: 2 patients (2 %) were Stage A, 12 (20 %) Stage B, 14 (23 %) Stage C, and 32 (53 %) Stage Dl. Twenty-two patients received adjuvant therapy (11 estramustine phosphate [Estracyt] and 11 cyclophosphamide [Cytoxan]) after radiation. Progression occurred in 22 patients (37 %): 6 (10 %) had local recurrence while 16 (27 %) failed distally. The incidence of late major complications was 12 percent.

UR - http://www.scopus.com/inward/record.url?scp=0024446562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024446562&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(89)90242-2

DO - 10.1016/0090-4295(89)90242-2

M3 - Article

VL - 34

SP - 115

EP - 119

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -